Edwards Lifesciences Corp (NYSE:EW)

102.26
Delayed Data
As of Aug 16
 -0.02 / -0.02%
Today’s Change
85.58
Today|||52-Week Range
131.73
-21.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$65.0B

Company Description

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring systems measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Contact Information

Edwards Lifesciences Corp.
One Edwards Way
Irvine California 92614
P:(949) 250-2500
Investor Relations:
(949) 250-6826

Employees

Shareholders

Mutual fund holders47.75%
Other institutional36.10%
Individual stakeholders1.11%

Top Executives

Michael A. MussallemChairman & Chief Executive Officer
Scott B. UllemChief Financial Officer & Vice President
Todd J. BrintonChief Scientific Officer & VP-Advanced Technology
Catherine M. SzymanVice President & General Manager-Critical Care
Arnold A. PinkstonVice President & General Counsel